Bleuler E. Dementia Praecox, Oder Gruppe Der Schizophrenien. Leipzig: Deuticke, 1911; Print.
2.Heckers S. Bleuler and the neurobiology of schizophrenia. Schizophr Bull. 2011;37(6):1131–5. https://doi.org/10.1093/schbul/sbr108.
Article PubMed PubMed Central Google Scholar
3.Ihara H, Berrios GE, McKenna PJ. The association between negative and dysexecutive syndromes in schizophrenia: a cross-cultural study. Behav Neurol. 2003;14(3–4):63–74. https://doi.org/10.1155/2003/304095.
CAS Article PubMed PubMed Central Google Scholar
4.Matsuda Y, Makinodan M, Morimoto T, Kishimoto T. Neural changes following cognitive remediation therapy for schizophrenia. Psychiatry Clin Neurosci. 2019;73(11):676–84. https://doi.org/10.1111/pcn.12912.
5.Chung DW, Fish KN, Lewis DA. Pathological basis for deficient excitatory drive to cortical parvalbumin interneurons in schizophrenia. Am J Psychiatry. 2016;173(11):1131–9. https://doi.org/10.1176/appi.ajp.2016.16010025.
Article PubMed PubMed Central Google Scholar
6.Ward RD, Winiger V, Higa KK, et al. The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia. Behav Neurosci. 2015;129(3):292–9. https://doi.org/10.1037/bne0000051.
CAS Article PubMed PubMed Central Google Scholar
7.Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51(3):199–214. https://doi.org/10.1001/archpsyc.1994.03950030035004.
CAS Article PubMed Google Scholar
8.Jodo E. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia. J Physiol Paris. 2013;107(6):434–40. https://doi.org/10.1016/j.jphysparis.2013.06.002.
9.Cadinu D, Grayson B, Podda G, Harte MK, Doostdar N, Neill JC. NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update. Neuropharmacology. 2018;142:41–62. https://doi.org/10.1016/j.neuropharm.2017.11.045.
CAS Article PubMed Google Scholar
10.Georgiev D, Arion D, Enwright JF, et al. Lower gene expression for KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal cortex in schizophrenia. Am J Psychiatry. 2014;171(1):62–71. https://doi.org/10.1176/appi.ajp.2013.13040468.
Article PubMed PubMed Central Google Scholar
11.Glausier JR, Lewis DA. GABA and schizophrenia: where we stand and where we need to go. Schizophr Res. 2017;181:2–3. https://doi.org/10.1016/j.schres.2017.01.050.
Article PubMed PubMed Central Google Scholar
12.Enwright JF, Sanapala S, Foglio A, Berry R, Fish KN, Lewis DA. Reduced labeling of parvalbumin neurons and perineuronal nets in the dorsolateral prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology. 2016;41(9):2206–14. https://doi.org/10.1038/npp.2016.24.
Article PubMed PubMed Central Google Scholar
13.Lazarus MS, Krishnan K, Huang ZJ. GAD67 deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex. Cereb Cortex. 2015;25(5):1290–6. https://doi.org/10.1093/cercor/bht322.
14.Fujihara K, Miwa H, Kakizaki T, et al. Glutamate decarboxylase 67 deficiency in a subset of GABAergic neurons induces schizophrenia-related phenotypes. Neuropsychopharmacology. 2015;40(10):2475–86. https://doi.org/10.1038/npp.2015.117.
CAS Article PubMed PubMed Central Google Scholar
15.Cohen SM, Tsien RW, Goff DC, Halassa MM. The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. Schizophr Res. 2015;167(1–3):98–107. https://doi.org/10.1016/j.schres.2014.12.026.
Article PubMed PubMed Central Google Scholar
16.Wu JQ, Chen DC, Tan YL, et al. Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia. J Psychiatr Res. 2016;76:9–15. https://doi.org/10.1016/j.jpsychires.2016.01.013.
17.Sasayama D, Hattori K, Wakabayashi C, et al. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J Psychiatr Res. 2013;47(3):401–6. https://doi.org/10.1016/j.jpsychires.2012.12.001.
18.Wei J, Hemmings GP. Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia. Med Hypotheses. 2005;64(3):547–52. https://doi.org/10.1016/j.mehy.2004.08.011.
CAS Article PubMed Google Scholar
19.Dinan TG, Borre YE, Cryan JF. Genomics of schizophrenia: time to consider the gut microbiome? Mol Psychiatry. 2014;19(12):1252–7. https://doi.org/10.1038/mp.2014.93.
CAS Article PubMed Google Scholar
20.Pedrini M, Massuda R, Fries GR, et al. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res. 2012;46(6):819–24. https://doi.org/10.1016/j.jpsychires.2012.03.019.
21.Song X, Fan X, Song X, et al. Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophr Res. 2013;150(1):269–73. https://doi.org/10.1016/j.schres.2013.07.044.
22.Pyndt Jørgensen B, Krych L, Pedersen TB, et al. Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia. Physiol Behav. 2015;141:32–9. https://doi.org/10.1016/j.physbeh.2014.12.042.
CAS Article PubMed Google Scholar
23.Feng HJ, Botzolakis EJ, Macdonald RL. Context-dependent modulation of alpha beta gamma and alpha beta delta GABA A receptors by penicillin: implications for phasic and tonic inhibition. Neuropharmacology. 2009;56(1):161–73. https://doi.org/10.1016/j.neuropharm.2008.08.010.
CAS Article PubMed Google Scholar
24.Lindquist CE, Dalziel JE, Cromer BA, Birnir B. Penicillin blocks human alpha 1 beta 1 and alpha 1 beta 1 gamma 2S GABAA channels that open spontaneously. Eur J Pharmacol. 2004;496(1–3):23–32. https://doi.org/10.1016/j.ejphar.2004.06.004.
CAS Article PubMed Google Scholar
25.Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–5. https://doi.org/10.1073/pnas.1102999108.
Article PubMed PubMed Central Google Scholar
26.Meckel KR, Kiraly DD. A potential role for the gut microbiome in substance use disorders. Psychopharmacology. 2019;236(5):1513–30. https://doi.org/10.1007/s00213-019-05232-0.
CAS Article PubMed PubMed Central Google Scholar
27.Patrono E, Matsumoto J, Nishimaru H, et al. Rewarding effects of operant dry-licking behavior on neuronal firing in the nucleus accumbens core. Front Pharmacol. 2017;8:536. https://doi.org/10.3389/fphar.2017.00536.
CAS Article PubMed PubMed Central Google Scholar
28.Lin L, Zheng LJ, Zhang LJ. Neuroinflammation, gut microbiome, and alzheimer’s disease. Mol Neurobiol. 2018;55(11):8243–50. https://doi.org/10.1007/s12035-018-0983-2.
CAS Article PubMed Google Scholar
29.Nguyen TT, Kosciolek T, Eyler LT, Knight R, Jeste DV. Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. J Psychiatr Res. 2018;99:50–61. https://doi.org/10.1016/j.jpsychires.2018.01.013.
Article PubMed PubMed Central Google Scholar
30.Nguyen TT, Kosciolek T, Maldonado Y, et al. Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects. Schizophr Res. 2019;204:23–9. https://doi.org/10.1016/j.schres.2018.09.014.
31.Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A. Gut microbiota in autism and mood disorders. World J Gastroenterol. 2016;22(1):361–8. https://doi.org/10.3748/wjg.v22.i1.361.
CAS Article PubMed PubMed Central Google Scholar
32.Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol. 2013;9(9):560–9.
33.Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4554–61. https://doi.org/10.1073/pnas.1000087107.
34.Yu ZT, Chen C, Kling DE, et al. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology. 2013;23(2):169–77. https://doi.org/10.1093/glycob/cws138.
CAS Article PubMed Google Scholar
35.Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079–89. https://doi.org/10.1038/nm.4185.
CAS Article PubMed Google Scholar
36.American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596.
37.Severance EG, Yolken RH, Eaton WW. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res. 2016;176(1):23–35. https://doi.org/10.1016/j.schres.2014.06.027.
38.McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67–76. https://doi.org/10.1093/epirev/mxn001.
39.Cardno AG, Jones LA, Murphy KC, et al. Dimensions of psychosis in affected sibling pairs. Schizophr Bull. 1999;25(4):841–50. https://doi.org/10.1093/oxfordjournals.schbul.a033423.
留言 (0)